(2017) uncovered remarkable heterogeneity and functional diversity among these cells (22)
A 2024 analysis of GLP-1 receptor agonists in older adults published in Obesity Reviews confirmed that the metabolic benefits, including improved insulin sensitivity and reduced cardiovascular risk, hold up in people over 65
RELATED: Retatrutide, Eli Lilly's next obesity drug, fueled dramatic weight loss in clinical trial To qualify, besides having Medicare drug coverage, you must have a body mass index of 35 or higher, or a BMI of 27 or higher alongside another health condition, such as a past heart attack or stroke, prediabetes or another from a list on the CMS website
Sites of pretranslational regulation by glucose of glucose-induced insulin release in pancreatic islets
One-carbon metabolism in health and disease